Which topical anesthetic creams can I prescribe?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Prescribable Topical Anesthetic Creams

You can prescribe lidocaine-based creams (including lidocaine/prilocaine combinations like EMLA), benzocaine, tetracaine, dibucaine, and dyclonine for topical anesthesia, with lidocaine/prilocaine (EMLA) and single-agent lidocaine formulations being the most commonly used and evidence-supported options for dermatologic procedures. 1

Primary Prescription Options

First-Line Agents

Lidocaine/Prilocaine (EMLA or generic equivalents)

  • 2.5% lidocaine/2.5% prilocaine eutectic mixture
  • Onset: 60 minutes with occlusive dressing
  • Duration: 60-120 minutes after removal
  • Use only on intact skin 1
  • Critical caveat: Risk of methemoglobinemia, particularly in neonates and infants—avoid large surface areas and prolonged application in these populations 1, 2

Single-Agent Lidocaine Creams

  • Available in 4%, 10%, and 20% concentrations
  • Onset: 2 minutes (though clinical efficacy for procedures typically requires 40-60 minutes under occlusion) 1, 3
  • Duration: 30-45 minutes
  • Safer alternative to EMLA when methemoglobinemia risk is a concern 2

Alternative Prescription Agents

Benzocaine

  • Onset: 5 minutes
  • Duration: 15-45 minutes
  • Warning: Can cause methemoglobinemia 1

Tetracaine-containing combinations

  • Often compounded with lidocaine and epinephrine (LET) or benzocaine (BLT)
  • LET formulation: 4% lidocaine, 1:2000 epinephrine, 0.5% tetracaine
  • BLT formulation: 20% benzocaine, 6% lidocaine, 4% tetracaine
  • These compounded formulations show lower systemic absorption than OTC preparations 4

Dibucaine

  • Onset: 5 minutes
  • Duration: 15-45 minutes
  • For mucous membranes 1

Dyclonine

  • Onset: 2-10 minutes
  • Duration: 60 minutes
  • For mucous membranes but not conjunctiva 1

Clinical Application Algorithm

For Dermatologic Procedures

  1. Minor procedures (biopsies, small excisions, laser treatments, botulinum toxin/filler injections):

    • Start with topical anesthesia alone 1
    • EMLA or 10% lidocaine cream applied for 60 minutes under occlusion

  2. Moderate procedures (larger excisions, wound repair):

    • Use topical anesthesia to reduce infiltration pain
    • Follow with infiltrative lidocaine as needed 1

  3. Pediatric facial/scalp lacerations:

    • LET gel is preferred (avoids injection pain and needle anxiety) 5
    • Avoid mucous membrane contact 5

For Pregnant/Nursing Women

  • Topical lidocaine is safe 1
  • Elective procedures should be postponed until after delivery
  • Urgent procedures should be delayed until second trimester when possible 1

Critical Safety Considerations

Avoid Compounded Non-Standard Doses

The evidence strongly warns against compounded mixtures in non-standard doses—these have resulted in severe toxicity and death 6, 4. When prescribing:

  • Use FDA-approved formulations when available
  • If compounding is necessary, use established formulations (LET, BLT) with documented safety profiles

Systemic Absorption Varies Dramatically

Research shows unpredictable interindividual absorption even with identical products 4. OTC preparations (Topicaine, LMX-4) demonstrated higher systemic absorption than prescription compounded formulations 4. Key safety measures:

  • Use the lowest effective dose
  • Avoid large surface areas, especially with occlusion
  • Monitor for signs of toxicity (perioral numbness, tinnitus, confusion, seizures)
  • Recommend supervision even for OTC products 4

Methemoglobinemia Risk

Both prilocaine (in EMLA) and benzocaine can cause methemoglobinemia 1, 2. This risk is highest in:

  • Neonates and infants
  • Large surface area application
  • Prolonged application times
  • Consider single-agent lidocaine formulations when this is a concern 2

What NOT to Prescribe

Cocaine-containing formulations are not recommended 1. While historically used, systematic reviews of 3,000 patients found no efficacy advantage over cocaine-free alternatives, with cocaine formulations having higher cost, potential for abuse, and greater adverse effects 1.

Efficacy Considerations

EMLA demonstrates superior efficacy to 10% lidocaine cream, particularly for onset and duration 3. However, the difference may not be clinically significant for many procedures, and lidocaine avoids methemoglobinemia risk. The choice depends on:

  • Procedure depth required (EMLA achieves 6.61 mm depth at 60 minutes vs 6.01 mm for 10% lidocaine) 3
  • Patient age and risk factors
  • Application time available (both require approximately 40-45 minutes minimum for acceptable anesthesia) 3

References

1
Guideline

guidelines for the use of local anesthesia in office-based dermatologic surgery.

Journal of the American Academy of Dermatology, 2016

5
Research

Topical anesthesia.

Canadian family physician Medecin de famille canadien, 1998

6
Research

Topical anesthetic creams.

Plastic and reconstructive surgery, 2008

Related Questions

What over‑the‑counter alternatives can replace Lidazone HC (lidocaine 3%/hydrocortisone 0.5%) cream?
What topical anesthetic cream is recommended for numbing the lips before filler injection?
What is the onset time of lidocaine (local anesthetic) for skin numbing?
Is it safe to use let gel for hemostasis on the nose, fingers, or similar external sites?
What over‑the‑counter topical oral anesthetic can be used to numb tongue sores?
Why is a sawtooth pattern seen in the inferior leads on an ECG?
In a 77-year-old woman with hypertension, heart failure with preserved ejection fraction, and stage IIIb chronic kidney disease who is receiving cefepime and vancomycin for pneumonia and now has encephalopathy manifested by somnolence, confusion, and EEG showing generalized periodic discharges with triphasic morphology, which intervention is most likely to improve her neurological symptoms: discontinue vancomycin, switch cefepime to piperacillin‑tazobactam, administer levetiracetam (Keppra), or start low-dose risperidone?
In a 75‑year‑old woman with persistent sterile pyuria, recent nitrofurantoin therapy, yellow vaginal discharge causing dyspareunia, negative urine culture, and hypertension treated with carvedilol, should vaginal clotrimazole be used?
What is atrial flutter?
Can an adult patient with stable blood pressure and eGFR ≥45 mL/min/1.73 m² start lisinopril and Jardiance (empagliflozin) on the same day?
What topical anesthetic (type, concentration, and application method) is safest and most effective for laser skin procedures, and what are the key safety considerations?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.